Savara Inc
(STU:YB4P)
€
3.94
0 (0%)
Market Cap: 647.07 Mil
Enterprise Value: 561.72 Mil
PE Ratio: 0
PB Ratio: 5.94
GF Score: 38/100 Savara Inc (STU:YB4P) Transcripts
- Savara Inc at Guggenheim Healthcare Talks Biotechnology Conference TranscriptFeb 07, 2024
- Savara Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Savara Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Savara Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Q2 2020 Savara Inc Earnings Call TranscriptAug 06, 2020€1.75 (+1.16%)Earnings
- Savara Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Q1 2020 Savara Inc Earnings Call TranscriptMay 07, 2020€2.22 (-1.77%)Earnings
- Savara Inc. - Special Call TranscriptApr 03, 2020
- Q4 2019 Savara Inc Earnings Call TranscriptMar 12, 2020€1.91 (-13.18%)Earnings
- Q3 2019 Savara Inc Earnings Call TranscriptNov 07, 2019€0.8 (-5.88%)Earnings
- Q2 2019 Savara Inc Earnings Call TranscriptAug 08, 2019€2.21 (+4.74%)Earnings
- Savara Inc Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) TranscriptJun 12, 2019
- Q1 2019 Savara Inc Earnings Call TranscriptMay 09, 2019€9.47 (-3.66%)Earnings
- Q4 2018 Savara Inc Earnings Call TranscriptMar 13, 2019€7.42 (+2.63%)Earnings
- 1